Works matching IS 13518216 AND DT 2009 AND VI 15 AND IP 6

Results: 32

Successful major and minor surgery using factor VIII inhibitor bypassing activity in patients with haemophilia A and inhibitors.

Published in:

Haemophilia, 2009, v. 15, n. 6, p. 1300, doi. 10.1111/j.1365-2516.2008.01873.x

By:

LAUROUA, P.;
FERRER, A.-M.;
GUÉRIN, V.

Publication type:

Article

Changing patterns of bleeding in patients with severe haemophilia A.

Published in:

Haemophilia, 2009, v. 15, n. 6, p. 1210, doi. 10.1111/j.1365-2516.2008.01876.x

By:

STEPHENSEN, D.;
TAIT, R. C.;
BRODIE, N.;
COLLINS, P.;
CHEAL, R.;
KEELING, D.;
MELTON, K.;
DOLAN, G.;
HAYE, H.;
HAYMAN, E.;
WINTER, M.

Publication type:

Article

Mosaics and haemophilia.

Published in:

Haemophilia, 2009, v. 15, n. 6, p. 1181, doi. 10.1111/j.1365-2516.2009.02003.x

By:

KASPER, C. K.;
BUZIN, C. H.

Publication type:

Article

Functional roles of the factor VIII B domain.

Published in:

Haemophilia, 2009, v. 15, n. 6, p. 1187, doi. 10.1111/j.1365-2516.2009.02026.x

By:

PIPE, S. W.

Publication type:

Article

Pharmacokinetic study of a high-purity factor IX concentrate (Factor IX Grifols®) with a 6-month follow up in previously treated patients with severe haemophilia B.

Published in:

Haemophilia, 2009, v. 15, n. 6, p. 1243, doi. 10.1111/j.1365-2516.2009.02052.x

By:

AZNAR, J. A.;
CABRERA, N.;
MATYSIAK, M.;
ZAWILSKA, K.;
GERCHEVA, L.;
ANTONOV, A.;
MONTAÑÉS, M.;
PÁEZ, A. M.;
LISSITCHKOV, T.

Publication type:

Article

How we treat: Venous thromboembolism prevention in haemophilia patients undergoing major orthopaedic surgery.

Published in:

Haemophilia, 2009, v. 15, n. 6, p. 1308, doi. 10.1111/j.1365-2516.2009.02060.x

By:

ZAKARIJA, A.;
ALEDORT, L.

Publication type:

Article

Undetected factor VIII in a patient with type 3 von Willebrands disease mistaken as severe haemophilia A.

Published in:

Haemophilia, 2009, v. 15, n. 6, p. 1258, doi. 10.1111/j.1365-2516.2009.02062.x

By:

MULLAH-ALI, A. M.;
CHAN, A. K.;
LILLICRAP, D.;
DECKER, K.;
SEROSKI, W.;
MOFFAT, K.;
WALKER, I.;
PAI, M. K.

Publication type:

Article

Monthly recombinant tissue plasminogen activator administration to implantable central venous access devices decreases infections in children with haemophilia.

Published in:

Haemophilia, 2009, v. 15, n. 6, p. 1272, doi. 10.1111/j.1365-2516.2009.02063.x

By:

JENG, M. R.;
O'BRIEN, M.;
WONG, W.;
ZOLAND, J.;
LEA, J.;
TANG, N.;
GLADER, B.

Publication type:

Article

Using a minigene approach to characterize a novel splice site mutation in human F7 gene causing inherited factor VII deficiency in a Chinese pedigree.

Published in:

Haemophilia, 2009, v. 15, n. 6, p. 1262, doi. 10.1111/j.1365-2516.2009.02064.x

By:

YU, T.;
WANG, X.;
DING, Q.;
FU, Q.;
DAI, J.;
LU, Y.;
XI, X.;
WANG, H.

Publication type:

Article

Emerging clinical concerns in the ageing haemophilia patient.

Published in:

Haemophilia, 2009, v. 15, n. 6, p. 1197, doi. 10.1111/j.1365-2516.2009.02066.x

By:

KONKLE, B. A.;
KESSLER, C.;
ALEDORT, L.;
ANDERSEN, J.;
FOGARTY, P.;
KOUIDES, P.;
QUON, D.;
RAGNI, M.;
ZAKARIJA, A.;
EWENSTEIN, B.

Publication type:

Article

Elimination capacity of a TSE-model agent in the manufacturing process of Alphanate®/Fanhdi®, a human factor VIII/VWF complex concentrate.

Published in:

Haemophilia, 2009, v. 15, n. 6, p. 1249, doi. 10.1111/j.1365-2516.2009.02067.x

By:

DIEZ, J. M.;
CABALLERO, S.;
BELDA, F. J.;
OTEGUI, M.;
GAJARDO, R.;
JORQUERA, J. I.

Publication type:

Article

Bypassing agent regimens and costs for prophylaxis in patients with inhibitors.

Published in:

2009

By:

GRINGERI, A.

Publication type:

Letter

Clinical variability of haemophilia A and B in Mexican families by factor V Leiden G1691A, prothrombin G20210A and MTHFR C677T/A1298C.

Published in:

2009

By:

LÓPEZ-JIMÉNEZ, J. J.;
BELTRÁN-MIRANDA, C. P.;
MANTILLA-CAPACHO, J. M.;
ESPARZA-FLORES, M. A.;
LÓPEZ GONZÁLEZ, L. C.;
JALOMA-CRUZ, A. R.

Publication type:

Letter

Successful liver surgery in a haemophilia patient with high titre factor VIII inhibitor.

Published in:

2009

By:

JONES, A. E.;
ROY, A.;
ARMSTRONG, T.;
REES, M.;
WELSH, F. K.

Publication type:

Letter

Pharmacokinetics, coagulation factor consumption and clinical efficacy in patients being switched from full-length FVIII treatment to B-domain-deleted r-FVIII and back to full-length FVIII.

Published in:

Haemophilia, 2009, v. 15, n. 6, p. 1237, doi. 10.1111/j.1365-2516.2009.02071.x

By:

REA, C.;
DUNKERLEY, A.;
SØRENSEN, B.;
RANGARAJAN, S.

Publication type:

Article

Gynaecological and obstetrical problems in women with different bleeding disorders.

Published in:

Haemophilia, 2009, v. 15, n. 6, p. 1291, doi. 10.1111/j.1365-2516.2009.02072.x

By:

SIBONI, S. M.;
SPREAFICO, M.;
CALÒ, L.;
MAINO, A.;
SANTAGOSTINO, E.;
FEDERICI, A. B.;
PEYVANDI, F.

Publication type:

Article

Thrombin generation and platelet activation induced by rFVIIa (NovoSeven®) and NN1731 in a reconstituted cell-based model mimicking haemophilia conditions.

Published in:

Haemophilia, 2009, v. 15, n. 6, p. 1318, doi. 10.1111/j.1365-2516.2009.02073.x

By:

ALJAMALI, M. N.;
KJALKE, M.;
HEDNER, U.;
EZBAN, M.;
TRANHOLM, M.

Publication type:

Article

Sites of initial bleeding episodes, mode of delivery and age of diagnosis in babies with haemophilia diagnosed before the age of 2 years: a report from The Centers for Disease Control and Prevention’s (CDC) Universal Data Collection (UDC) project.

Published in:

Haemophilia, 2009, v. 15, n. 6, p. 1281, doi. 10.1111/j.1365-2516.2009.02074.x

By:

KULKARNI, R.;
SOUCIE, J. M.;
LUSHER, J.;
PRESLEY, R.;
SHAPIRO, A.;
GILL, J.;
MANCO-JOHNSON, M.;
KOERPER, M.;
MATHEW, P.;
ABSHIRE, T.;
DIMICHELE, D.;
HOOTS, K.;
JANCO, R.;
NUGENT, D.;
GERAGHTY, S.;
EVATT, B.

Publication type:

Article

Ethanol lock therapy for the treatment of catheter-related infections in haemophilia patients.

Published in:

Haemophilia, 2009, v. 15, n. 6, p. 1267, doi. 10.1111/j.1365-2516.2009.02075.x

By:

RAJPURKAR, M.;
BOLDT-MACDONALD, K.;
MCLENON, R.;
CALLAGHAN, M. U.;
CHITLUR, M.;
LUSHER, J. M.;
BECKER, C.

Publication type:

Article

The new age of haemophilia.

Published in:

2009

By:

LAMBING, A.;
KACHALSKY, E.

Publication type:

Letter

Joint outcomes in patients with haemophilia: the importance of adherence to preventive regimens.

Published in:

Haemophilia, 2009, v. 15, n. 6, p. 1219, doi. 10.1111/j.1365-2516.2009.02077.x

By:

BERNTORP, E.

Publication type:

Article

Multiplex ligation-dependent probe amplification to detect a large deletion within the von Willebrand gene.

Published in:

2009

By:

ACQUILA, M.;
BOTTINI, F.;
DI DUCA, M.;
VIJZELAAR, R.;
MOLINARI, A. C.;
BICOCCHI, M. P.

Publication type:

Letter

Efficacy assessment of a new clotting factor concentrate in haemophilia A patients, including prophylactic treatment.

Published in:

Haemophilia, 2009, v. 15, n. 6, p. 1215, doi. 10.1111/j.1365-2516.2009.02079.x

By:

UIJL, I. DEN;
MAUSER-BUNSCHOTEN, E. P.;
ROOSENDAAL, G.;
SCHUTGENS, R.;
FISCHER, K.

Publication type:

Article

Polymorphism in factor VII gene modifies phenotype of severe haemophilia.

Published in:

Haemophilia, 2009, v. 15, n. 6, p. 1228, doi. 10.1111/j.1365-2516.2009.02080.x

By:

JAYANDHARAN, G. R.;
NAIR, S. C.;
POONNOOSE, P. M.;
THOMAS, R.;
JOHN, J.;
KESHAV, S. K.;
CHERIAN, R. S.;
DEVADARISHINI, M.;
LAKSHMI, K. M.;
SHAJI, R. V.;
VISWABANDYA, A.;
GEORGE, B.;
MATHEWS, V.;
CHANDY, M.;
SRIVASTAVA, A.

Publication type:

Article

Acquired factor VIII inhibitor in patient infected with HIV: a casual association or a prone immunological setting?

Published in:

2009

By:

MIGLIORE, E.;
ALLIONE, A.;
DUTTO, L.;
BERNARDI, E.;
VETTORAZZI, L. A.;
RICCA, M.;
TARTAGLINO, B.;
RAPEZZI, D.;
GRASSO, M.

Publication type:

Letter

Venous thrombosis prophylaxis in haemophilics undergoing major orthopaedic surgery: a survey of haemophilia treatment centres.

Published in:

2009

By:

PRADHAN, S. M.;
KEY, N. S.;
BOGGIO, L.;
PRUTHI, R.

Publication type:

Letter

Type IIb von Willebrand disease with angiodysplasias and refractory gastrointestinal bleeding successfully treated with thalidomide.

Published in:

2009

By:

NOMIKOU, E.;
TSEVRENIS, V.;
GAFOU, A.;
BELLIA, M.;
THEODOSSIADES, G.

Publication type:

Letter

Profiling of factor VIII mutations in Korean haemophilia A.

Published in:

Haemophilia, 2009, v. 15, n. 6, p. 1311, doi. 10.1111/j.1365-2516.2009.02086.x

By:

HWANG, S. H.;
KIM, M. J.;
LIM, J. A.;
KIM, H. C.;
KIM, H. S.

Publication type:

Article

Effect of the F8 mutation c.1538-2A>T on pre-mRNA splicing.

Published in:

2009

By:

LAURIE, A. D.;
SMITH, M. P.

Publication type:

Letter

Non-catheter related internal jugular vein thrombosis in a patient with severe haemophilia A.

Published in:

2009

By:

RAO, A. A. N.;
KUMAR, R.;
ARTEAGA, G. M.;
GALARDY, P. J.;
RODRIGUEZ, V.

Publication type:

Letter

The national registry of haemophilia A and B in Spain: results from a census of patients.

Published in:

2009

By:

AZNAR, J. A.;
ABAD-FRANCH, L.;
CORTINA, V. R.;
MARCO, P.

Publication type:

Letter

Pregnancy in a patient with severe factor X deficiency.

Published in:

2009

By:

MAMOPOULOS, A.;
VAKALOPOULOU, S.;
LEFKOU, E.;
FILELI, A.;
GARIPIDOU, V.;
MAVROMATIDIS, G.;
DINAS, K.;
KARAGIANNIS, V.

Publication type:

Letter

Works matching IS 13518216 AND DT 2009 AND VI 15 AND IP 6

Successful major and minor surgery using factor VIII inhibitor bypassing activity in patients with haemophilia A and inhibitors.

Changing patterns of bleeding in patients with severe haemophilia A.

Mosaics and haemophilia.

Functional roles of the factor VIII B domain.

Pharmacokinetic study of a high-purity factor IX concentrate (Factor IX Grifols<sup>®</sup>) with a 6-month follow up in previously treated patients with severe haemophilia B.

How we treat: Venous thromboembolism prevention in haemophilia patients undergoing major orthopaedic surgery.

Undetected factor VIII in a patient with type 3 von Willebrands disease mistaken as severe haemophilia A.

Monthly recombinant tissue plasminogen activator administration to implantable central venous access devices decreases infections in children with haemophilia.

Using a minigene approach to characterize a novel splice site mutation in human F7 gene causing inherited factor VII deficiency in a Chinese pedigree.

Emerging clinical concerns in the ageing haemophilia patient.

Elimination capacity of a TSE-model agent in the manufacturing process of Alphanate<sup>®</sup>/Fanhdi<sup>®</sup>, a human factor VIII/VWF complex concentrate.

Bypassing agent regimens and costs for prophylaxis in patients with inhibitors.

Clinical variability of haemophilia A and B in Mexican families by factor V Leiden G1691A, prothrombin G20210A and MTHFR C677T/A1298C.

Successful liver surgery in a haemophilia patient with high titre factor VIII inhibitor.

Pharmacokinetics, coagulation factor consumption and clinical efficacy in patients being switched from full-length FVIII treatment to B-domain-deleted r-FVIII and back to full-length FVIII.

Gynaecological and obstetrical problems in women with different bleeding disorders.

Thrombin generation and platelet activation induced by rFVIIa (NovoSeven<sup>®</sup>) and NN1731 in a reconstituted cell-based model mimicking haemophilia conditions.

Sites of initial bleeding episodes, mode of delivery and age of diagnosis in babies with haemophilia diagnosed before the age of 2 years: a report from The Centers for Disease Control and Prevention’s (CDC) Universal Data Collection (UDC) project.

Ethanol lock therapy for the treatment of catheter-related infections in haemophilia patients.

The new age of haemophilia.

Joint outcomes in patients with haemophilia: the importance of adherence to preventive regimens.

Multiplex ligation-dependent probe amplification to detect a large deletion within the von Willebrand gene.

Efficacy assessment of a new clotting factor concentrate in haemophilia A patients, including prophylactic treatment.

Polymorphism in factor VII gene modifies phenotype of severe haemophilia.

Acquired factor VIII inhibitor in patient infected with HIV: a casual association or a prone immunological setting?

Venous thrombosis prophylaxis in haemophilics undergoing major orthopaedic surgery: a survey of haemophilia treatment centres.

Type IIb von Willebrand disease with angiodysplasias and refractory gastrointestinal bleeding successfully treated with thalidomide.

Profiling of factor VIII mutations in Korean haemophilia A.

Effect of the F8 mutation c.1538-2A>T on pre-mRNA splicing.

Non-catheter related internal jugular vein thrombosis in a patient with severe haemophilia A.

The national registry of haemophilia A and B in Spain: results from a census of patients.

Pregnancy in a patient with severe factor X deficiency.